Noveris Health Sciences Inc. (CNSX: NVRS)
Health Care · Pharmaceuticals · CA
CA$0.16
-27.27% today · -68.0% 1Y
Noveris Health Sciences Inc. (CNSX: NVRS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $6.80M.
Over the last twelve months the share price has lost 68.0%, trading between 0.12 and 3.00.
Tweenvest scores Noveris Health Sciences Inc. across four factors: quality 17/100. Its strongest factor is quality.
NVRS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.80M
- Revenue (TTM)
- —
- P/E
- 0.49
- EPS
- 0.33
- Dividend yield
- —
- Beta (5Y)
- -5.44
- 52-week high
- CA$3.00
- 52-week low
- CA$0.12
- Avg volume (3M)
- —
- Shares outstanding
- 58.55M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,251.95 | +0.40% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.12 | +0.03% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $155.00 | +2.88% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.42 | +1.61% |
Figures last refreshed Aug 18, 2026.